Literature DB >> 25857417

PET/CT for Pancreatic Malignancy: Potential and Pitfalls.

Priyanka Jha1, Bijan Bijan2.   

Abstract

Pancreatic malignancy carries a poor prognosis and is the fourth leading cause of cancer-related deaths in the United States. Although conventional imaging with CT and MR remains the main imaging modality, recent times have seen an increase in the applications of PET/CT in the evaluation of pancreatic malignancy. Newer data are becoming available, highlighting the advantages, limitations, and pitfalls in PET/CT imaging of the pancreas. This article highlights the applications of PET/CT in various stages of management of pancreatic malignancy and compares these with conventional imaging with CT and MR.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  PET/CT; PET/MR; pancreas adenocarcinoma; pancreatic adenocarcinoma; pancreatic malignancy

Mesh：

Year:  2015        PMID： 25857417     DOI： 10.2967/jnmt.114.145458

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN： 0091-4916


  9 in total

1.  Isolated submandibular lymph node metastasis in pancreatic adenocarcinoma.

Authors:  Taiwo Oyebola; Akash Mavilakandy; Peter Conboy; Neil Bhardwaj
Journal:  Ann R Coll Surg Engl       Date:  2019-02-04       Impact factor: 1.891

2.  Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.

Authors:  Yizhen Pang; Long Zhao; Qihang Shang; Tinghua Meng; Liang Zhao; Liuxing Feng; Shuangjia Wang; Ping Guo; Xiurong Wu; Qin Lin; Hua Wu; Weipeng Huang; Long Sun; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-15       Impact factor: 9.236

3.  Utility of 18F-FDG PET/CT in Management of Pancreatic and Periampullary Masses-Prospective Study from a Tertiary Care Center.

Authors:  Chandra Teja Reddy S; Krishna Mohan V S; Sai Moulika Jeepalem; Ranadheer Manthri; Tekchand Kalawat; Venkatarami Reddy V; Narendra Hulikal; Vijaya Lakshmi Devi B
Journal:  Indian J Surg Oncol       Date:  2021-09-23

4.  Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.

Authors:  Venkata Subramanian Krishnaraju; Rajender Kumar; Bhagwant Rai Mittal; Vishal Sharma; Harjeet Singh; Ritambhra Nada; Amanjit Bal; Manish Rohilla; Harmandeep Singh; Surinder S Rana
Journal:  Eur Radiol       Date:  2020-10-01       Impact factor: 5.315

5.  Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.

Authors:  Kirstin A Zettlitz; Wen-Ting K Tsai; Scott M Knowles; Naoko Kobayashi; Timothy R Donahue; Robert E Reiter; Anna M Wu
Journal:  J Nucl Med       Date:  2018-03-30       Impact factor: 10.057

6.  Developing Consilience Medicine: Positron Emission Tomography Scan and Transcriptomics in Pancreatic Cancer.

Authors:  Seong Hun Kim; Seung Ok Lee
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

7.  Assessment of pancreatic colloid carcinoma using 18F-FDG PET/CT compared with MRI and enhanced CT.

Authors:  Lei Jiang; Qiying Tang; Cedric M Panje; Hongting Nie; Guochao Zhao; Hongcheng Shi
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

8.  Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma.

Authors:  Yi Lao; John David; Arman Torosian; Veronica Placencio; Yalin Wang; Andrew Hendifar; Wensha Yang; Richard Tuli
Journal:  Phys Imaging Radiat Oncol       Date:  2019-01-04

Review 9.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.